Physician profile
Daniel Sung Jun Ahn
NPI 1629531066
$1,980.69
in general payments reported to CMS, 2019-2025
7 companies · $1,981 in 2025
The $1,981 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099 · Travel and Lodging: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.15 |
| Travel and Lodging | $881.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $755.84 | 2025 | Wavewriter Alpha Prime 16, General - Therapies |
| Medtronic, INC. | $706.16 | 2025 | Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $244.86 | 2025 | Evoke |
| Spr Therapeutics, INC | $133.99 | 2025 | Sprint Pns System |
| Abbott Laboratories | $95.66 | 2025 | Eterna |
| Ethicon US, LLC | $27.52 | 2025 | Echelon Flex, Echelon Circular, Harmonic |
| Pacira Pharmaceuticals Incorporated | $16.66 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.